Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening

NCT03938623 | Unknown

• 1 other identifier: 2016IAN913
• Study Type: observational
• Target: 274
• Locations: 1 country
• Sites: 1

Brief Summary

Context : Colorectal cancer (CRC) mass screening has been implemented in France since 2008. Participation rates remain too low. The objective of this study is to test if the implementation of a training course focused on communication skills (whether in-person or e-learning) among general practitioners (GP) would increase the delivery of gFOBT and CRC screening participation among the target population of each participating GP. Method : Pragmatic controlled cluster randomized trial with 2 parallel groups: Control versus Educational Intervention Intervention ; six hour educational training either in person or through e-learning The Main objective: is to evaluate the effectiveness of an educational intervention teaching physicians the patient-centered approach, either in-person or through e-learning, by evaluating their patients' participation in colorectal cancer (CRC) screening for all risk categories.

Conditions

Colorectal Cancer

Keywords

colorectal cancer; general practitioners; the patient-centered approach

Outcome Measures

Primary Outcomes (1)

• number of patients screened positive using the patient-centered approach after training of face to face training or e-learning

  Evaluate the effectiveness of face to face training or e-learning training to use the patient-centered approach

  1 year

Study Arms (2)

Training

Teaching general practitioners to use the patient-centered approach when suggesting colorectal cancer screening

Other: Training

Control

General Practitioners not using the patient-centered approach

Interventions

Training OTHER

Teaching general practitioners to use the patient-centered approach when suggesting colorectal cancer screening

Also known as: The patient-centered approach

Training

Eligibility Criteria

• Age: 50 Years - 74 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All general practitioners practicing in the Île-de-France, Languedoc-Roussillon, Loire-Atlantique, Midi-Pyrénées, Poitou-Charentes, or Provence-Alpes-Cote-d'Azur regions will be requested Their patients are eligible if they are 50-74 years old and reside in one of the above regions.

You may qualify if:

• Patients aged 50 to 74,
• Residing in the regions of Île-de-France, Languedoc-Roussillon, Loire-Atlantique, Midi-Pyrenees, Poitou-Charentes, and Provence-Alpes-Côte-D'azur,
• Registered on the AMELI file of general practitioners participating in beginning of the study, before the training (ie the patients who have declared as a doctor one of the participating general practitioners).
• Affiliation to the general social security scheme

You may not qualify if:

• Patients excluded from screening for medical reasons (colorectal cancer or symptoms such as presence of red or black blood in the stool, other pathologies in non-priority treatment and screening)
• Patient having performed a Hemoccult® test / test immunological test for less than 2 years or had colonoscopy for less than 5 years.
• Patient who has declared as a treating physician one of the participating physicians for the duration of the study.
• Patient who did not consult for the duration of the study

Sponsors & Collaborators

• Collège de la Médecine Générale, France: lead
• National Cancer Institute, France: collaborator

Study Sites (1)

Département de Médecine Générale

Paris, Idf, 75018, France

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Study Officials

• AUBIN-AUGER M ISABELLE, MD, Pr

  COLLEGE DE LA MEDECINE GENERALE

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 25, 2019
• First Posted: May 6, 2019
• Study Start: January 24, 2018
• Primary Completion: December 31, 2019
• Study Completion: December 31, 2020
• Last Updated: May 6, 2019

Record last verified: 2019-04

Locations

FR (1)